Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing Institute of Respiratory Medicine.
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5604-5617. doi: 10.26355/eurrev_202005_21346.
The kidney injury molecule-1 (uKIM-1) and neutrophil gelatinase-associated lipocalin (uNGAL, sNGAL) have been demonstrated to be diagnostic biomarkers for acute kidney injury (AKI) in a variety of diseases. However, both of them were not well validated in sepsis patients with acute kidney injury.
This was a prospective and observational study which was performed in the three intensive care units of the Beijing Chao-Yang Hospital. Over a 12-month period, 174 patients (70 sepsis patients, 69 sepsis with AKI and 35 controls) were enrolled. Blood and urinary specimens were collected at admission as soon as possible (within 24 hours) and KIM-1 and NGAL levels were tested.
Levels of uKIM-1, uNGAL, sNGAL were significantly higher in the sepsis patients who developed AKI compared to those sepsis with no-AKI (0.88 ng/ml (0.37, 2.14) vs. 1.21 ng/ml (0.67, 3.26) p=0.003, 63.54 ng/ml (21.66, 125.45) vs. 249.85 ng/ml (86.60, 585.97) p<0.001, and 108.08 ng/ml (67.74, 212.22) vs. 200.01 ng/ml (102.76, 300.77) p=0.001, respectively). sKIM-1 also had significant differences between the two groups (83.98 pg/ml (54.00,147.08) vs. 193.41 pg/ml (106.90, 430.60) p<0.001). The four biomarkers (uKIM-1, sKIM-1, uNGAL, sNGAL) all could be predictive for AKI, and the areas under the receiver operating characteristic curves (AUROC) were 0.607, 0.754, 0.768, 0.658, respectively. The uNGAL was an independent risk factor for septic AKI, and the AUROC was 0.768 (95% CI: 0.689 to 0.835). The uNGAL and sNGAL were related to the prognosis of sepsis.
Our results showed that NGAL was a promising biomarker of septic AKI. Like the uKIM-1, the sKIM-1 could early predict the occurrence of septic AKI too, but both of them did not have the predictive value in judging the severity of AKI and the prognosis of sepsis.
肾损伤分子-1(uKIM-1)和中性粒细胞明胶酶相关脂质运载蛋白(uNGAL,sNGAL)已被证明是多种疾病急性肾损伤(AKI)的诊断生物标志物。然而,在伴有急性肾损伤的脓毒症患者中,这两种标志物均未得到充分验证。
这是一项前瞻性观察性研究,在北京朝阳医院的三个重症监护病房进行。在 12 个月的时间内,共纳入了 174 名患者(70 名脓毒症患者,69 名脓毒症合并 AKI 和 35 名对照者)。入院后尽快(24 小时内)采集血和尿标本,检测 KIM-1 和 NGAL 水平。
与无 AKI 的脓毒症患者相比,发生 AKI 的脓毒症患者的 uKIM-1、uNGAL 和 sNGAL 水平显著升高(0.88ng/ml(0.37,2.14)比 1.21ng/ml(0.67,3.26),p=0.003;63.54ng/ml(21.66,125.45)比 249.85ng/ml(86.60,585.97),p<0.001;108.08ng/ml(67.74,212.22)比 200.01ng/ml(102.76,300.77),p=0.001)。sKIM-1 在两组间也有显著差异(83.98pg/ml(54.00,147.08)比 193.41pg/ml(106.90,430.60),p<0.001)。这四种生物标志物(uKIM-1、sKIM-1、uNGAL、sNGAL)均能预测 AKI,受试者工作特征曲线下面积(AUROC)分别为 0.607、0.754、0.768、0.658。uNGAL 是脓毒症 AKI 的独立危险因素,AUROC 为 0.768(95%CI:0.689 至 0.835)。uNGAL 和 sNGAL 与脓毒症的预后有关。
我们的研究结果表明,NGAL 是脓毒症 AKI 的一个有前途的生物标志物。与 uKIM-1 一样,sKIM-1 也可以早期预测脓毒症 AKI 的发生,但两者均无预测 AKI 严重程度和脓毒症预后的价值。